parathyroid scintigraphy spect/ct - snm
TRANSCRIPT
![Page 1: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/1.jpg)
Parathyroid Scintigraphy SPECT/CT
Harvey A. Ziessman, MD
Nuclear Medicine
Department of Radiology
Johns Hopkins University
![Page 2: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/2.jpg)
• Elevated s. calcium and parthormone
• Primary – Adenoma 85%
• Secondary – low calcium, renal
failure, 4 gland hyperplasia
• Tertiary – renal failure, autonomous
• Imaging is for localization
Hyperparathyroidism - Diagnosis
![Page 3: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/3.jpg)
Sensitivity - NM, US, CT, MR
Author NM US CT MR Bonjer 81% 72% Staudenherz 78 58 Light 87 53 Tamaki 92 88 56 % Geati 95 81 83 Calxas 95 75 40 33% Wakamatsu 75 75 63 Average 88% 72% 60% 48%
![Page 4: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/4.jpg)
Parathyroid Radiopharmaceuticals
• 1962 Cobalt-57 vitamin B-12
• 1964 Se-75 methionine
• 1977 Cesium-131
• 1979 Tl-201 chloride
• 1989 Tc-99m sestamibi (Cardiolite)
• 1996 Tc-99m tetrofosmin (Myoview)
• 1996 F-18 fluorodeoxyglucose (FDG)
• 1997 C-11 methionine
![Page 5: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/5.jpg)
• Planar imaging - thyroid subtraction
• Dual-phase planar imaging
• SPECT – early or delayed
• SPECT/CT
• Combinations of these methods
Parathyroid MIBI – Methodology
![Page 6: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/6.jpg)
Dual-isotope subtraction imaging
MIBI I-123 MIBI –Tc-99m
![Page 7: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/7.jpg)
Sensitivity of Tc-99m sestamibi Subtraction (I-123 or Tc-99m)
Adenoma Hyperplasia Author Date #Pts. O’Doherty 1989 51 97% Wei 1994 23 92% 67% Hindie 1995 30 96% 67% Chen 1995 35 76% 50% Johnston 1996 46 78% Borley 1996 56 94% Hindie 1997 65 95% 80% Average 89% 66%
![Page 8: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/8.jpg)
Tc-99m Sestamibi
• Differential washout of thyroid and
parathyroid – Doherty MJ, et al. JNM, ’92
Thyroid Parathyroid
MIBI
Tl-201 Tl-201
MIBI
![Page 9: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/9.jpg)
Sestamibi – Dual phase
• Diagnostic utility of dual-phase method – Taillefer R, et al. JNM 1992
2 hrs 10 min
![Page 10: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/10.jpg)
Tc-99m Sestamibi
• Differential washout – thyroid , para
– Parathyroid slower washout 60%
– Similar rate of washout
– Rapid washout
• Interpretation based on focal uptake
– Focal increase compared to thyroid
– Juxta-thyroidal/extra-thyroidal
![Page 11: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/11.jpg)
Sensitivity of dual-phase MIBI Adenoma Hyperplasia Author Date # Pts. Taillefer 1992 23 90% Lee 1995 39 93% 60% Mazzezo 1996 73 82% McHenry 1996 124 81% Malhotra 1996 51 100% 56% Blocklet 1997 55 84% Blanco 1998 41 92% 63%
Average 88% 60%
![Page 12: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/12.jpg)
Traditional Approach to Surgery
• Bilateral neck exploration
• Experienced surgeons
>90% success rate
• Value of scintigraphy
was questioned
![Page 13: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/13.jpg)
• Small incision
• Fewer complications – hypoparathyroidism
– recurrent laryngeal nerve injury
• Shorter operating time/hospitalization
• This requires preoperative localization
Minimally invasive parathyroidectomy
![Page 14: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/14.jpg)
Embryology of
parathyroid glands
Descend from 3rd and 4th
pharyngeal pouches
![Page 15: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/15.jpg)
Superior glands
Phitayakorn, Am J Surg 2006
Inferior glands
77 %
22 %
41 %
Parathyroid usual gland location
57 %
![Page 16: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/16.jpg)
• Cephalad
carotid bifurcation
• Posterior retro-esophageal
• Anterior to the thyroid
• Inferior pericardium
Parathyroid (ectopic) locations
![Page 17: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/17.jpg)
Location of
ectopic glands
Superior glands Inferior
glands
Embryologic
descent
“ectopic”glands
![Page 18: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/18.jpg)
Ectopic glands • Superior (40%)
– Tracheo-esophageal groove (43%)
– Retro- or para-esophageal (29%)
– Post. superior mediastinum (14%)
• Inferior (60%)
– Thymus/thyrothymic ligament (47%)
– Ant. superior mediastinum (22%)
![Page 19: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/19.jpg)
Superior vs. inferior glands Why is this important?
• Superior glands
• Different arterial supply
• Behind the recurrent laryngeal nerve
• Thus, surgery has more risk
• Surgeons would like to know
![Page 20: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/20.jpg)
SPECT
Advantages
• Improves contrast resolution
• Allows 3-dimensional localization
– R/L, sup./inf., ant./post.
![Page 21: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/21.jpg)
SPECT – Tc-99m MIBI
• 338 patients - hyperparathyroidism
• Prospective study - 1994 to 2000,
• SPECT (triple-headed) at 2.5 hrs
Civelek, Udelsman, Surgery 2002; 131:149
![Page 22: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/22.jpg)
SPECT – Tc-99m MIBI
• Correct lateralization (R, L) 87%
• Precise localization (sup., inf.) 82%
• Ectopic glands 93%
• Reoperative explorations 98%
Civelek, et al, Surgery 2002; 131:149
![Page 23: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/23.jpg)
SPECT – Tc-99m MIBI
• 56 false positives (14%)
21 thyroid adenomas
6 thyroid cancer
29 unexplained
Civelek, Udelsman, Hopkins, Surgery 2002; 131:149
![Page 24: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/24.jpg)
SPECT – Tc-99m MIBI
• Ectopic glands 19% (74) – 6 carotid sheath – 8 intra-thyroidal – 33 retro-esophageal space – 8 thymus – 5 mediastinum
– 14 superior glands – were inferior and posterior to lower poles
Civelek, Surgery 2002; 131:149
![Page 25: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/25.jpg)
99mTc MIBI – SPECT vs. Planar
Sensitivity
Authors Pts. Planar SPECT
Billotey 1996 92 .86 .91
Chen 1997 66 .79 .78
Moka 2000 55 .56 .95
Schachter 2004 82 .78 .96
Lavely 2007 110 .79 .79
Nichols 2008 462 .84 .83
![Page 26: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/26.jpg)
SPECT - Early vs. Delayed
Sensitivity Author # Patients Early Delayed
Perez Monte 37 .91 .74
Chen 49 .78
Schachter 82 .96
Civilek 338 .87
Nichols 462 .83
![Page 27: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/27.jpg)
• Combines
– functional information of sestamibi
– anatomical information of CT
• Offers the potential to improve
• localization
• improve specificity
SPECT/CT?
![Page 28: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/28.jpg)
• To determine:
– If hybrid SPECT/CT improves
localization over SPECT or planar
– If dual-time period SPECT/CT or
SPECT improves accuracy for
localization over a single-time period
Hopkins 2004-2006
![Page 29: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/29.jpg)
Methods - Patient Population
• 210 consecutive patients
191 – primary hyperparathyroidism
192 – no prior parathyroid surgery
110 – had surgical resection by the time
of data analysis
103 – Single adenomas
![Page 30: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/30.jpg)
SPECT/CT
• 2.5 mA low
dose x-ray tube
• CT acquisition
time: 10 min
• Rad dose:1 mSv
(100 mrem)
![Page 31: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/31.jpg)
Methods - Imaging Protocol
• 30 mCi, Tc-99m Sestamibi
• Imaging at 10 min and 2 hrs
– Planar – ANT, RAO, LAO
– SPECT/CT of neck/thorax
![Page 32: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/32.jpg)
Methods
• 6 image sets
Early Planar Late Planar
Early SPECT Late SPECT
Early SPECT/CT Late SPECT/CT
• 13 combinations of image sets
• 19 reads of each patient’s images
• 2 reading groups each with 2 readers
![Page 33: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/33.jpg)
Single image Set Sens. PPV AUC
Planar - early 34% 75% 67%
Planar - delayed 45 73 72
SPECT - early 54 77 76
SPECT - delayed 54 73 76
SPECT/CT early 62 83 81
SPECT/CT delayed 54 70 76
Single-study RESULTS
<.03
NS
NS
![Page 34: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/34.jpg)
Image Sets Sens. PPV AUC
Planar - early/delayed .57 .80 .78
SPECT- early/delayed .62 .82 .82
SPECT/CT - early/delayed .72 .87 .86
Paired studies - RESULTS
NS
<.05
![Page 35: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/35.jpg)
Localization - Single Adenoma
Image Sets PPV AUC
* Early SPECT/CT-Late SPECT 91% 86%
* Early SPECT/CT-Late SPECT/CT 87% 86%
* Early SPECT/CT-Late Planar 86% 86%
Early SPECT-Late SPECT/CT 83% 82%
Early SPECT-Late SPECT 79% 81%
Early planar-Late planar 79% 78%
![Page 37: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/37.jpg)
10 min
2 hrs
ANT RAO LAO
![Page 38: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/38.jpg)
Maximal
intensity
projections
MIPS
![Page 39: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/39.jpg)
MIPS
![Page 40: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/40.jpg)
Delayed
SPECT/CT
![Page 41: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/41.jpg)
![Page 42: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/42.jpg)
![Page 43: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/43.jpg)
![Page 44: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/44.jpg)
![Page 45: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/45.jpg)
![Page 46: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/46.jpg)
![Page 47: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/47.jpg)
![Page 48: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/48.jpg)
![Page 49: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/49.jpg)
![Page 50: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/50.jpg)
![Page 51: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/51.jpg)
![Page 52: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/52.jpg)
Early
SPECT/CT
![Page 53: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/53.jpg)
![Page 54: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/54.jpg)
![Page 55: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/55.jpg)
Delayed
Early
![Page 56: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/56.jpg)
MIPS
![Page 57: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/57.jpg)
Delayed SPECT
![Page 58: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/58.jpg)
![Page 59: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/59.jpg)
![Page 60: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/60.jpg)
![Page 61: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/61.jpg)
![Page 62: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/62.jpg)
![Page 63: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/63.jpg)
![Page 64: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/64.jpg)
![Page 65: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/65.jpg)
![Page 66: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/66.jpg)
![Page 67: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/67.jpg)
![Page 68: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/68.jpg)
![Page 69: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/69.jpg)
POST ANT
3-D volume rendering - CTA and SPECT parathyroid scan
Nakada, et al. SNM 2010
![Page 70: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/70.jpg)
Conclusion - SPECT/CT
• Combines functional information
from Tc-99m sestamibi SPECT
with CT anatomy
• Dual-phase SPECT-CT provides
the surgeon with accurate pre-op
three-dimensional localization
![Page 71: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/71.jpg)
SAM Questions
• Which cell type MOST likely is
responsible for sestamibi uptake
A. Chief
B. Follicular
C. Oxyphil
D. Parafollicular
![Page 72: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/72.jpg)
SAM Questions
• Which cell type MOST likely is
responsible for sestamibi uptake
A. Chief – secretes PTH
B. Follicular – thyroid hormone
C. Oxyphil – correct, mitochondria
D. Parafollicular – calcitonin
![Page 73: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/73.jpg)
SAM Questions In primary hyperpara, which most
commonly causes false negatives
A. Lymphoma
B. Multigland disease
C. Single gland disease
D. Thyroid adenoma
![Page 74: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/74.jpg)
SAM Questions In primary hyperpara, what most
commonly causes false negatives
A. Lymphoma
B. Multigland disease - correct
C. Single gland disease
D. Thyroid adenoma
![Page 75: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/75.jpg)
![Page 76: Parathyroid Scintigraphy SPECT/CT - SNM](https://reader031.vdocuments.net/reader031/viewer/2022020705/61fb977d2e268c58cd600007/html5/thumbnails/76.jpg)
Nuclear Medicine
PET
Johns Hopkins
Radiology